Login to Your Account



Financings Roundup


Friday, August 31, 2012
• Catalyst Pharmaceutical Partners Inc., of Coral Gables, Fla., closed its registered direct offering of 4 million shares of common stock and warrants to purchase 1.2 million shares of common stock, generating gross proceeds of $6 million. Roth Capital Partners acted as the exclusive placement agent.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription